FOR REMOTE PATIENT MONITORING

RESP® Biosensor

Manage lung health from hospital to home with objective monitoring of symptoms

FDA 510(k) Class II | CE Mark | HIPAA Compliant

cough monitoring RESP biosensor

Technology Overview

Developed by an asthma patient, the RESP® Biosensor offers clinicians and healthcare teams a novel approach to improve disease surveillance with at-risk patients.

  • Continuous lung sound monitoring: High-fidelity wearable device continuously captures lung sounds to extend the range of stethoscope auscultation.
  • Patient-friendly device: Wireless, discreet design that respects patient comfort and lifestyle.
  • Clinically validated: Demonstrated reliability, accuracy, and ease of use in several patient populations. View publications
Strados Cough Monitoring Solution

OVERVIEW VIDEO

“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient from having major complications”

– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center

Track Patient Progress Objectively and Remotely

Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.

KEY FEATURES

  • Passive & continuous
  • Wireless & lightweight
  • HIPAA compliant
  • Reimbursable under RTM & RPM codes
  • 24+ hour battery life
  • Rechargeable
  • EHR/telehealth integration
  • Proprietary machine learning algorithms* for event detection

*Machine learning algorithms not FDA cleared

Lung sound recordings captured by the biosensor are depicted visually as spectrograms

Cough

Wheeze

Crackles

Actively Seeking Research Collaborations

We’re actively seeking clinical and academic collaborators to expand the evidence base for objective cough and lung sound monitoring. Partners may be eligible for in-kind support.

RESP® Biosensor Care Settings

Ambulatory Care

 

  • Remote monitoring of at-risk COPD & Asthma patients
  • Interstitial lung diseases
  • Heart failure
  • Pulmonary Rehabilitation

Acute Care

 

  • In-patient status monitoring
  • Chronic, complex care management
  • Hospital at Home
  • Tele-ICUs

Post-Acute Care

 

  • Post-discharge hospital to home
  • Post-surgical recovery and rehabilitation
  • Skilled-nursing and long-term care facilities

Practice Application

At-risk COPD patient is discharged from hospital

Patient is prescribed RESP®  Biosensor for two weeks

On day 5, clinician receives  alert of increased coughing and wheezing

Clinician checks in with patient virtually and adjusts treatment plan to avoid a readmission

Publications

View our clinical validation, whitepapers and case studies

Stepwise Validation Program

Increasing Abnormal Lung Sounds After Discharge Predicts COPD Readmission

Poster Presentation, CHEST, 2023

Objective Cough Monitoring

Remote Auscultation At Home After Asthma Exacerbation: A Case from Discharge to Readmission

Poster Presentation, American Thoracic Society, 2020

Results of Clinical performance testing in Chronic lung diseases
Results of Clinical Performance Testing in Chronic Lung Diseases

Poster Presentation, American Thoracic Society, 2022

Talk to our Team

Reach out to explore using the RESP Biosensor in your practice